Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index; 11 of the 26 sources its claims cite were checked for support.
Abstract
Compared to national figures, all disorders were associated with substantially lower life expectancy: 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women. Highest reductions were found for men with schizophrenia (14.6 years lost) and women with schizoaffective disorders (17.5 years lost).
Overview
CoChat Summary
TL;DR
Using a large South London mental health case register linked to national mortality data, the paper estimates markedly reduced life expectancy at birth for people with serious mental illness and related disorders. The largest losses were 14.6 years for men with schizophrenia and 17.5 years for women with schizoaffective disorder.
Key findings
- Among 31,719 eligible people aged 15+ with SMI, 1,370 died during 2007–09.
- Compared with national figures, all disorders were associated with 8.0 to 14.6 life years lost for men and 9.8 to 17.5 life years lost for women.
- The greatest reductions were 14.6 years lost for men with schizophrenia and 17.5 years lost for women with schizoaffective disorders.
- In the analyzed sample, life expectancy at birth ranged from 62.8 years (men with schizophrenia) to 69.4 years (men with schizoaffective disorder), and from 64.1 years (women with schizoaffective disorder) to 74.4 years (women with depressive disorders).
Methods
- Retrospective register-based analysis using the SLAM Case Register Interactive Search (CRIS), a secondary mental health care database covering southeast London.
- Included people diagnosed before end-2009 with schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorder, depressive episode, or recurrent depressive disorder and under active review during 2007–09; final analytic sample was 31,719 people aged 15+.
- Estimated life expectancy at birth by gender and diagnosis using national mortality returns (2007–09) and Chiang’s abridged life table method in 5-year age groups.
Limitations
- The authors state that the secondary healthcare setting may limit generalizability, especially for substance use disorders and depressive disorders, because register cases are likely a more severe and unrepresentative subset of community cases.
- Diagnostic categories overlapped, but the study analyzed disorders separately; the paper says comorbidity between SMI and substance use disorders should not be assumed to be captured because source data reflected primary diagnoses rather than co-occurrence.
- Evident from the text: the study uses administrative/register data and compares to national norms, so it cannot fully disentangle causal pathways or all confounding factors behind the mortality differences.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
7 Valid · 1 Not valid · 10 Not checked · 19 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Introduction Concerns about premature mortality among people with mental disorders have been increasing [1]–[6]. Higher general and specific causes of mortality in all or specific age groups have been identified for people with serious mental illnesses (SMI, which might include schizophrenia, schizoaffective disorder, bipolar disorder, and depressive psychosis) in a range of settings [1], [2], [7]–[11], although most report relative risks or rates of mortality rather than life expectancy – which is arguably a more important index for shaping policy since it takes premature mortality into account and has been widely used for other risk exposures such as smoking, diabetes, obesity, ethnicity and socioeconomic status [12]–[17]. Of the few studies to measure this outcome, clients with SMI from public mental health agencies in eight US states from 1997 to 2000 were found to have lower life expectancies of 13 to more than 30 years compared to the general population (depending on the year and state) [2], and a loss of 8.8 life years (14.1 years for men and 5.7 years for women) was estimated in a comparison between people treated for SMI and the general population in Massachusetts, US [1]. A Swedish study using a nationwide hospital discharge registry reported substantial gaps in life expectancy at age 30 for main mental disorder categories compared to the general population, particularly for functional psychosis other than schizophrenia / affective psychosis (15.9 years lost), substance abuse (15.6 years lost), and organic psychosis (14.8 years lost) among men and organic psychosis (22.6 years lost), mental retardation (14.7 years lost), and substance abuse (18.8 years lost) among women [18]. Preliminary strategies for preventing premature deaths among people with SMI have been suggested, emphasizing the management of suicide risk and physical illness, minimum polypharmacy, and improvement of accessibility to physical health care [19]. Despite healthcare improvements, there has been little evidence of benefit on life expectancy in people with SMI [1], [20], [21], and further research is urgently required [22]. We reported excess mortality for people with diagnoses of SMI, as well as for depressive and substance use disorders, drawing on data from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register, which covers comprehensive secondary mental healthcare provision to a large geographically defined community, by standardized mortality ratios (SMRs) [23]. Nonetheless, equal weighting is used for each age group in the calculation of SMRs, which is insufficient for highlighting the impact of premature mortality among younger age groups in the study cohort.
What the sources say
- Not checked — no full text of the sourcecites [1] BP Dembling, 1999, Life expectancy and causes of death in a population treated for serious mental illness., Psychiatr Serv source
- Supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs source
The opening discussion states that life expectancy for people with severe mental illness is decreasing, supporting the claim that it has shown little benefit. The discussion of interventions describes improvements in physical-health risk factors but says only a minority of patients receive them. Page numbers are not provided in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [21] LA Chwastiak, 2009, The unchanging mortality gap for people with schizophrenia., Lancet source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23].”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [23] CK Chang, 2010, All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study., BMC Psychiatry source
The Results report that SMRs standardized using London mortality data were comparable to those using England and Wales data. The Discussion states that this sensitivity analysis did not reveal any meaningful differences. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry source
The Cardiovascular Disease section reports that approximately 59% of excess deaths in a meta-analysis of patients with schizophrenia were attributed to natural causes. The FOR CLINICAL USE section also reports that most excess deaths in a study of patients with bipolar disorder were due to natural causes. These findings support the cited background statement, particularly for the severe mental disorders the paper discusses. (LLM, conf=0.88)
- Partly supportedcites [5] S Brown, 2000, Causes of the excess mortality of schizophrenia., Br J Psychiatry sourceExperimental — accuracy not yet measured
The Natural cause mortality section reports that natural causes accounted for 63% of excess mortality, and Overall mortality says about two-thirds of extra deaths were from natural causes. The study concerns people with schizophrenia; it does not establish the same predominance across mental disorders generally. Page numbers are not provided in the supplied passages. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [30] DN Baxter, 1996, The mortality experience of individuals on the Salford Psychiatric Case Register. I. All-cause mortality., Br J Psychiatry source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33]”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Discussion Using a large secondary mental healthcare database in southeast London linked to national mortality returns, we confirmed substantially shortened life expectancies at birth for all serious mental disorder groups investigated compared to national norms. Largest reductions were found for men with schizophrenia, women with schizoaffective disorders, and both men and women with substance use disorders. In previous analyses of these cohorts, raised standardised mortality ratios (SMRs) had been described [23], although the picture was less dramatic because SMRs reflect less well the impact of premature mortality at earlier life stages. In a US study conducted by the Massachusetts Department of Mental Health from 1989 to 1994, service users with SMI were found to have lost 8.8 years of potential life (14.1 years for men and 5.7 for women) on average compared to the general population, a stronger impact for men and weaker impact for women compared to findings from our sample. However, SMI was not specifically defined in the Massachusetts study other than stating “evidence of serious dysfunction” as an inclusion criterion [1], which might explain the discrepancy. A Swedish analysis of national discharges from 1978–82 reported more complex data on life expectations at given ages. For the lowest age described (30 years), subsequent life expectancy associated with schizophrenia was 7.9 years lower in men and 9.5 years lower in women [18] – i.e. similar to the finding for women in our sample but less strong for men. Further international research is clearly required to compare the potential impacts of SMI on life expectancy in different settings since this may provide clues as to systems of care which may help to maximise this. Mortality in SMI is recognised to be raised and underlying causes may be multiple. As well as our own findings, any psychiatric diagnosis was associated with a 65% higher than expected total mortality in a case register study in a British primary care cohort [30]. In the same setting, a three-fold elevated mortality was found for coronary heart disease in young adults with SMI, and a more than two-fold increased mortality of stroke in all age groups [8]. Long-term antipsychotic use and adverse lifestyle choices (e.g. obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3], [19], [20], [22], [31]–[33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent deaths. Because the causal pathways between mental disorder and premature mortality are multiple, and because life years lost as an outcome measures not only the effect of an exposure on risk of mortality but also its differential effect across the age range, it is difficult to interpret with certainty the gender variation in findings – i.e. the strongest effects of schizophrenia in men and schizoaffective disorder in women. Clearly the two disorders overlap substantially at a genetic and biological level. It is possible that the impact of co-occurring affective disorder is stronger in women due to specific biological or social vulnerability. However, against this, there was no difference in the impact of bipolar disorder between men and women and the impact of depressive episode/disorder was stronger in men. Alternative explanations may lie in the clinical practice of assigning diagnoses and gender differences here – for example, if there was preferential inclusion in women of severe personality disorders with transient psychotic episodes within this diagnostic group. Further research is clearly required to clarify this issue. Life expectancy is a commonly used indicator for how longevity may be impaired by specific long-term exposures (e.g. smoking, obesity, ethnicity, and socioeconomic status) or chronic states of ill-health or risk (e.g. diabetes mellitus) [12], [13], [15]–[17], [34], and provides an alternative platform to discriminate the influences of different exposures for the purpose of highlighting premature mortality at younger ages in potentially vulnerable groups [25]. It is therefore primarily a measure of impact and should be seen as complementary to more common studies using measures of effect, such as SMR statistics. As a measure, life expectancy analyses provide an important means of communicating impact on survival to policy makers and lay audiences. This approach also allows the impact of different exposures to be compared in a way which cannot be inferred from SMR outputs. As a case in point, considering the impact of other well-recognised exposures and comparing these with the potential impact of SMI, in a Japanese study of life expectancy from age 40, smoking was the most important predictor of six lifestyle related exposures (smoking, alcohol consumption, walking duration, sleep duration, consumption of green leafy vegetables, and obesity), current smoking being associated with around four to five life years lost for both genders [12], [13]. Considering 2005 life expectancy levels in the USA (75.1 years for men and 80.3 years for women), current and previous smoking was associated with 2.5 years lower life expectancy for men and 1.8 years lower life expectancy for women [17]. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers [16], and in New Zealand Census records in 1996, the gap in life expectancy between current and never smokers was 7.6 years in men and 6.7 for women [15]. Diabetes was reported to reduce life expectancy at age 15 by 1.3 years for men and 2.0 years for women in Canada [14], and a BMI of 40–45 kg/m2 was associated with a 10 year reduction of life expectancy at age 35 compared to a BMI 22.5–25 kg/m2 [35]. The potential impact of having a serious mental illness (or a substance use disorder or a depressive episode requiring secondary care contact) on life expectancy is therefore at least comparable and at worse substantially higher than effects of individual well-recognised exposures, although clearly the mechanisms through which mental disorders are associated with premature mortality will include the effects of these individual risk factors (for example, smoking behaviour, risk of diabetes, etc.) as well as other factors (such as risk of suicide or accidents and direct effects of mental distress on cardiovascular risk). Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3], [5], [30], [31], [36]–[38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39]–[41]. If improving overall survival is to be considered as an alternative priority, much more efforts are clearly required to address the challenges of improving general health in people with mental disorders through medical services, socioeconomic support, and physical health promotion strategies [19]. Strengths of the study described include the large sample size and nationwide coverage of mortality, as well as the context of complete electronic clinical records. Potential limitations include the secondary healthcare setting; this should present no problem for high penetrance disorders, such as schizophrenia and bipolar disorder, where most cases will have received secondary care input. However, findings for substance use disorders and depressive disorders should be viewed with circumspection since those appearing on a secondary care register are likely to be an unrepresentative (and probably more severe) subset of community cases. Ultimately, the findings for life expectancy should be taken as referring to people with these mental disorders who had made contact with secondary mental health services within the given time period and are not necessarily applicable to all cases in a given community. Diagnostic categories overlapped, but only a minority (5.7%) of people had received more than one mental disorder diagnosis during the surveillance period. Nevertheless, comorbidity between SMI and substance use disorders should not be assumed to be captured as the source data reflected primary diagnoses rather than co-occurrence. Also we did not attempt to capture co-occurring or changing diagnoses which present potentially complex issues for analysis in a secondary care sample and which we felt were beyond the scope of this initial report. Although SLAM is a major academic as well as clinical centre, mental disorders on the Case Register are likely to be broadly generalizable to other urban settings in the UK (the SLAM catchment covers a range of residence areas from inner city to suburban settings but does not include any rural areas). Life expectancy comparisons of regional data to national norms may be problematic. However, in a sensitivity analysis of SMR data, the use of London comparators did not meaningfully change findings [23]. Also, from administrative data, life expectancy at birth for population of the four catchment area boroughs in 2007–09 (ranging from 76.3–79.5 years for males and 81.1–82.9 years for females), were not substantially different to national estimates [42]. Our results demonstrate the substantial impact of serious mental illness on life expectancy and highlight importance of developing strategies to prevent premature mortality among people with SMI and other major mental disorders. Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3], [4], [7], [8], [22], [31]. Physical health risk assessments and assertive intervention by primary and secondary medical services have been proposed and have resulted in improvements [20], [43]. Continued monitoring of mortality trends in people with mental disorders will be required to evaluate the impact of policy changes as they occur.
What the sources say
- Partly supportedcites [3] A Fagiolini, 2009, The effects of undertreated chronic medical illnesses in patients with severe mental disorders., J Clin Psychiatry sourceExperimental — accuracy not yet measured
The Medication Side Effects section says atypical antipsychotics increase the likelihood of cardiovascular disease, and the lifestyle discussion links inactivity, poor diet, and smoking to coronary heart disease. Our copy does not establish a risk specifically from long-term antipsychotic use or address illicit drug use as a cardiovascular risk factor; it discusses cardiovascular disease rather than cardiovascular events specifically. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [19] P Auquier, 2006, Mortality in schizophrenia., Pharmacoepidemiol Drug Saf source
- Partly supportedcites [20] R Gray, 2009, Physical health and severe mental illness: if we don't do something about it, who will?, Int J Ment Health Nurs sourceExperimental — accuracy not yet measured
In “Why then do our patients die?” (page not provided), Gray identifies obesity, smoking, lack of exercise and poor diet as prevalent lifestyle risks in people with severe mental illness, and says some prescribed medications increase cardiometabolic disease risk. The passage does not specify long-term antipsychotic use or link illicit drug use to cardiovascular events; it mentions drug misuse only as another influence on health. (LLM, conf=0.85)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All the life expectancies at birth for specific mental disorders were significantly different between genders based on their 95% confidence intervals.”
§ Life Expectancy at Birth for People with Serious Mental Illness and Other Major Disorders from a Secondary Mental Health Care Case Register in London > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
6 more claims
Create a free account to see all 37 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“people with mental health disorders have a life expectancy eight years less than the general population”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The reductions of life expectancy among persons with bipolar disorder seem to be slightly smaller: approximately 10 years in a study from London [43], and 13 years in a Danish study made on data similar to the Danish data used in Table 3 [44].”
From Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. (2013) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates to a 10-20 year shortened life expectancy 3,4”
From Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This mortality gap translates into a 10-20 year shortened life expectancy (3,4) and appears to be widening (5).”
From Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study from the United Kingdom (Chang et al. 2011) found that life expectancy was reduced by 14.6 years among persons with schizophrenia.”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Chang et al. 2011
Experimental — accuracy not yet measured
Citations
Cites
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“. For British doctors born in 1900–1930 and followed up for fifty years, continued smoking was associated with around 10 years life lost, compared to lifelong non-smokers”
BackgroundSchizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881 · cited 1×
“Although the prevention of suicides and violent deaths are likely to be an important component, other causes of excess mortality should not be ignored, including cardiovascular diseases, cancer, and diabetes [3,4,7,8,22,31].”
Background(2006) · Europe PMC (PubMed Central) · Cited by 1,299
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087 · cited 2×
“Excess mortality associated with mental disorders has been demonstrated to be predominantly due to ‘natural’ causes [3,5,30,31,36–38], although mental health service provision is often focused on preventing more rare outcomes of suicide and violent death [39–41].”
BackgroundDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
The unhealthy lifestyle of people with schizophrenia
BROWN, S., BIRTWISTLE, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 874 · cited 1×
“obesity, smoking, poor diet, illicit drug use, and physical inactivity) are implicated in increased risk of cardiovascular events in these populations [3,19,20,22,31–33] and clearly need higher levels of consideration in order to improve health and survival, as well as the better-known risks of suicide and violent dea…”
Background
Cited by
Items 201–300 of 706
Barton, B. B., Beqiri‐Zagler, A., Engl, K., Rihs, L., & Musil, R. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01043-8 · Cited by 34
Abnormal reward valuation and event-related connectivity in unmedicated major depressive disorder
Rupprechter, S., Stankevicius, A., Huys, Q. J. M., Series, P., & Steele, J. D. (2021) · Psychological Medicine · doi:10.1017/s0033291719003799 · Cited by 27
Pálinkás, A., Sándor, J., Papp, M., Kőrösi, L., Falusi, Z., Pál, L., Bélteczki, Z., Rihmer, Z., & Döme, P. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1545-7 · Cited by 29
Jensen, K. G., Correll, C. U., Rudå, D., Klauber, D. G., Decara, M. S., Fagerlund, B., Jepsen, J. R. M., Eriksson, F., Fink‐Jensen, A., & Pagsberg, A. K. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.01.015 · Cited by 27
Daganatos megbetegedések és a depresszió: rövid irodalmi áttekintés
Szelei, A., & Döme, P. (2020) · Orvosi Hetilap · doi:10.1556/650.2020.31759 · Cited by 35
Age-related changes in physiology in individuals with bipolar disorder
Mutz, J., Young, A. H., & Lewis, C. M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.027 · Cited by 30
Nyatega, C. O., Li, Q., Adamu, M. J., & Kawuwa, H. B. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1054380 · Cited by 28
Keeley, T., Khan, H., Pinfold, V., Williamson, P. R., Mathers, J. M., Davies, L. M., Sayers, R., England, E., Reilly, S., Byng, R., et al. (2015) · Trials · doi:10.1186/s13063-015-0553-0 · Cited by 33
“People with schizophrenia and bipolar disorder have a significantly reduced life expectancy, increased rates of unemployment and experience of stigma leading to reduced self-confidence and self-esteem [4,5].”
The terminal, the futile, and the psychiatrically disordered
Cholbi, M. J. (2013) · International Journal of Law and Psychiatry · doi:10.1016/j.ijlp.2013.06.011 · Cited by 26
“…conducted in London found dramatic differences in lifespan among those with psychiatric disorders compared to the general population, particularly for those with schizoid disorders: 8.0 to 14.6 fewer years for men with such disorders, and 9.8 to 17.5 fewer years for women (Chang et al., 2011).”
BackgroundInfluentialEdgcomb, J. B., Shaddox, T. R., Hellemann, G. S., & Brooks, J. O. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.05.002 · Cited by 31
A Human-Interpretable Machine Learning Approach to Predict Mortality in Severe Mental Illness
Banerjee, S., Lió, P., Jones, P. B., & Cardinal, R. N. (2021) · Schizophrenia · doi:10.1038/s41537-021-00191-y · Cited by 30
“Mortality among patients with severe mental illnesses (SMI) is too often premature 3,4 .”
BackgroundCharlson, F., Diminic, S., & Whiteford, H. (2015) · Asia & the Pacific Policy Studies · doi:10.1002/app5.93 · Cited by 29
Ratliff, J. C., Palmese, L. B., Reutenauer, E. L., & Tek, C. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.rapa.030113 · Cited by 29
Burns, A., Strawbridge, J., Clancy, L., & Doyle, F. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.05.005 · Cited by 31
Starace, F., Mungai, F., Baccari, F., & Galeazzi, G. M. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-017-1468-8 · Cited by 31
“The diagnosis of schizophrenia, for example, has been associated with a mean reduction in life expectancy of 18 years [8].”
BackgroundDas‐Munshi, J., Chang, C., Dregan, A., Hatch, S. L., Morgan, C., Thornicroft, G., Stewart, R. J., & Hotopf, M. H. (2020) · Psychological Medicine · doi:10.1017/s0033291720001087 · Cited by 34
“…and bipolar diagnoses are uncommon below the age of 15 years, we substituted under-15 years’ mortality rates from the population of England and Wales from 2011, as this year was the midpoint of the cohorts; This methodology has been used previously for these populations (Chang et al., 2011).”
MethodResultSelf-citationStewart, R. J., Martin, E., & Broadbent, M. T. M. (2020) · medRxiv · doi:10.1101/2020.06.13.20130419 · Cited by 26
Self-citationLower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12‐month study
Bond, D. J., Torres, I. J., Lee, S. S., Kozicky, J.-M., da Silveira, L. E., Dhanoa, T., Lam, R. W. M., & Yatham, L. N. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12674 · Cited by 28
“8% (3) 0% (0) Mania (YMRS ≥ 20) 0% (0) 1.”
BackgroundSerious Mental Illness and the Role of Primary Care
Planner, C., Gask, L., & Reilly, S. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0458-8 · Cited by 30
Tsai, K., Chung, T.-C., Lee, C., Chou, Y.-M., Su, C., Shen, S., Lin, C., & Chou, F. H. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0716-9 · Cited by 25
“Nevertheless, life expectancy which takes premature mortality into account and has been widely used for other physical health problems such as smoking, diabetes, obesity, ethnicity and SES, was lower in people with schizophrenia than in general population [45].”
BackgroundGenetic Risk for Psychiatric Disorders and Telomere Length
Palmos, A., Breen, G. D., Goodwin, L., Frissa, S., Hatch, S. L., Hotopf, M. H., Thuret, S., Lewis, C. M., & Powell, T. R. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00468 · Cited by 31
“, 2012), and increases the risk of early mortality (Chang et al., 2011).”
BackgroundSelf-citationAltered reward anticipation: Potential explanation for weight gain in schizophrenia?
Grimm, O., Kaiser, S., Plichta, M. M., & Tobler, P. N. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.029 · Cited by 28
“As shown in a recent meta-analysis (Bak et al., 2014), the life expectancy of patients with severe mental illness is lower than that of the general population (Chang et al., 2011).”
Accelerated aging in bipolar disorders: An exploratory study of six epigenetic clocks
Bourdon, C., Étain, B., Spano, L., Belzeaux-R, R., Leboyer, M., Delahaye‐Duriez, A., Ibrahim, E. C., Lutz, P.-É., Gard, S., Schwan, R., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115373 · Cited by 25
Rosenbaum, S., Nijjar, S., Watkins, A., Garwood, N., Sherrington, C., & Tiedemann, A. (2014) · International Journal of Mental Health Nursing · doi:10.1111/inm.12057 · Cited by 26
“People diagnosed with a serious mental illness (SMI) have a reduced life expectancy of between 10 and 32 years when compared to the general population (Chang et al. 2011; Miller et al. 2006).”
BackgroundIntegrated physical and mental healthcare: an overview of models and their evaluation findings
Coates, D., Coppleson, D., & Schmied, V. A. (2020) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000215 · Cited by 27
Hemmings, L., & Soundy, A. (2020) · Physiotherapy · doi:10.1016/j.physio.2020.01.001 · Cited by 37
Parmar, M., Ma, R., Attygalle, S., Mueller, C., Stubbs, B., Stewart, R. J., & Perera, G. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02079-9 · Cited by 27
“The SLaM BRC Case Register has been described in detail [17] and has supported many studies, [19, 20].”
ResultSelf-citationChang, C.-K., Chesney, E., Teng, W.-N., Hollandt, S., Pritchard, M., Shetty, H., Stewart, R. J., McGuire, P. K., & Patel, R. (2021) · Psychological Medicine · doi:10.1017/s0033291721002257 · Cited by 50
“We only included patients from a single mental health trust in South East London, an urban area with high levels of ethnic diversity, socioeconomic inequality, substance use and social isolation.”
BackgroundInfluentialSelf-citationSu, Y., Chang, C., Hayes, R. D., Perera, G., Broadbent, M. T. M., To, D., Hotopf, M. H., & Stewart, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105312 · Cited by 29
Self-citationNational funding for mental health research in Finland, France, Spain and the United Kingdom
Hazo, J., Gandré, C., Leboyer, M., Obradors‐Tarragó, C., Belli, S. R., McDaid, D., Park, A., Maliandi, M. V., Wahlbeck, K., Wykes, T., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.06.008 · Cited by 26
Post, R. M., Altshuler, L. L., Leverich, G. S., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Grunze, H., et al. (2014) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000116 · Cited by 27
“…ranged from 13 years in the state of Virginia to more than 30 years in some western states (Colton and Manderscheid, 2006; Newcomer and Hennekens, 2007), whereas lesser numbers of years lost are typically reported in countries outside the United States (Chang et al., 2011, 2012; Osby et al., 2001).”
BackgroundChildhood maltreatment and the medical morbidity in bipolar disorder: a case–control study
Hosang, G. M., Fisher, H. L., Uher, R., Cohen‐Woods, S., Maughan, B., McGuffin, P., & FARMER, A. E. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0099-z · Cited by 27
Watkins, A., Rosenbaum, S., Ward, P. B., Patching, J., Denney‐Wilson, E., & Stein‐Parbury, J. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00321 · Cited by 25
“What determines whether nurses provide physical health care to consumers with serious mental illness? Arch Psychiatr Nurs (2014) 28(2):87–93.”
BackgroundInfluentialLiu, H., Tian, Y., Liu, Y., Nigatu, Y. T., & Wang, J. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2019.01.007 · Cited by 23
Optimizing placement of residential shelters for human trafficking survivors
Maass, K. L., Trapp, A. C., & Konrad, R. (2019) · Socio-Economic Planning Sciences · doi:10.1016/j.seps.2019.100730 · Cited by 23
Gałecki, P., & Bliźniewska-Kowalska, K. M. (2019) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/115208 · Cited by 30
“Depressive disorders shorten the predicted survival time by up to 10 years [14].”
BackgroundModeling smoking-attributable mortality among adults with major depression in the United States
Tam, J., Taylor, G. M. J., Zivin, K., Warner, K. E., & Meza, R. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106241 · Cited by 24
Hardy, S., Hinks, P., & Gray, R. J. (2013) · International Journal of Social Psychiatry · doi:10.1177/0020764013483721 · Cited by 28
“SMI is classed as a long-term condition with a life expectancy that is reduced by 12–19 years (Chang et al., 2011; Laursen, 2011).”
BackgroundGodin, O., Leboyer, M., Belzeaux-R, R., Bellivier, F., Loftus, J., Courtet, P., Dubertret, C., Gard, S., Henry, C., Llorca, P., et al. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13239 · Cited by 22
Archer, T., & Kostrzewa, R. M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9543-y · Cited by 21
“…schizoaffective disorders, and bipolar dis- order are at increased risk for developing severe health problems that include diabetes, cardiovascular disease, and respiratory disease—all contributing to significantly reduced life expectancy (Chang et al. 2010, 2011; Hayes et al. 2012).”
BackgroundWhite, J., Gutacker, N., Jacobs, R., & Mason, A. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.09.036 · Cited by 26
Simon, N., & Verdoux, H. (2017) · L Encéphale · doi:10.1016/j.encep.2017.05.003 · Cited by 25
Brose, L. S., Simonavičius, E., & McNeill, A. D. (2017) · Psychological Medicine · doi:10.1017/s0033291717002021 · Cited by 23
“Smoking is the main contributor to a gap in life expectancy of 8–22 years between those with and without mental health problems (Brown et al. 2010; Chang et al. 2011; Wahlbeck et al. 2011; Lawrence et al. 2013; Tam et al. 2016).”
BackgroundBailey, J. M., Hansen, V., Wye, P. M., Wiggers, J., Bartlem, K. M., & Bowman, J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5314-z · Cited by 24
Personalized and precision medicine as informants for treatment management of bipolar disorder
Perugi, G., Rossi, P. D., Fagiolini, A. M., Girardi, P., Maina, G., Sani, G., & Serretti, A. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000260 · Cited by 33
“…analysis of very large databases could provide valuable information on many aspects of bipolar disorder for research and clinical care, such as incidence, prevalence (Allebeck, 2009), decreased life expectancy (Chang et al., 2011) and trends in prescribing medication (Baldessarini et al., 2007).”
BackgroundBartlem, K. M., Bailey, J. M., Metse, A. P., Asara, A., Wye, P. M., Clancy, R., Wiggers, J., & Bowman, J. (2017) · International Journal of Mental Health Nursing · doi:10.1111/inm.12411 · Cited by 27
“Kingdom, and the United States estimate this life expectancy gap to be between 10 and 30 years, depending upon setting, psychiatric diagnosis, and severity of illness (Chang et al. 2011; Laursen et al. 2013; Lawrence et al. 2013; Olfson et al. 2015; Walker et al. 2015).”
BackgroundBitter, I., Szekeres, G., Cai, Q., Fehér, L., Gimesi-Országh, J., Kunovszki, P., Khoury, A. C. E., Döme, P., & Rihmer, Z. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1771 · Cited by 29
Chan, V. K. Y., Cheung, E. C. L., Chan, S. S. M., Knapp, M. R. J., Hayes, J., Fan, M., Lai, F. T. T., Luo, H., Lum, T. Y. S., Wong, R. S. M., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100426 · Cited by 27
Crapanzano, K. A., Deweese, S., Pham, D., Le, T., & Hammarlund, R. (2023) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-022-09829-w · Cited by 30
Hasnawati, S., Usman, M., Elfaki, F. A. M., Faisol, A., & Russel, E. (2024) · International Journal of Energy Economics and Policy · doi:10.32479/ijeep.16303 · Cited by 32
Charrel, C.-L., Plancke, L., Génin, M., Defromont, L., Ducrocq, F., Vaïva, G., & Danel, T. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0913-1 · Cited by 23
“All of the studies until now have shown that premature death in patients with mental illness is due to persisting risk factors such as smoking, sedentary lifestyle and diabetes [25] and the high prevalence of physical illnesses [26].”
BackgroundChang, C., Chen, C.-Y., Broadbent, M., Stewart, R. J., & O’Hara, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014846 · Cited by 21
Self-citationProtective Factors for Early Psychotic Phenomena Among Children of Mothers With Psychosis
Riches, S., Arseneault, L., Raha, B.-N., Manar, A., Crush, E., & Fisher, H. L. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00750 · Cited by 23
“Psychotic disorders, especially schizophrenia, are responsible for a substantial proportion of disability worldwide (1), are associated with 10–25 years shorter life expectancy (2), and place a huge burden on families, health services, and society (3–5) Current treatments are unable to provide a cure; therefore, early…”
BackgroundOpen Dialogue for psychosis or severe mental illness
Pavlovic, R. Y., Pavlovic, A., & Donaldson, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012384 · Cited by 24
Coates, D., Coppleson, D., & Travaglia, J. (2021) · Journal of Interprofessional Care · doi:10.1080/13561820.2020.1862771 · Cited by 26
Causes of mortality in a large population-based cohort of psychiatric patients in Southern Europe
Girardi, P., Schievano, E., Fedeli, U., Braggion, M., Nuti, M., & Amaddeo, F. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.01.050 · Cited by 21
Rozing, M. P., Jønsson, A. B. R., Køster‐Rasmussen, R., Due, T. D., Brodersen, J., Bissenbakker, K. H., Siersma, V., Mercer, S. W., Guassora, A. D., Kjellberg, J., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00906-z · Cited by 33
“It is projected that among people with SMI, defined as psychotic conditions, bipolar disorder, and severe depression [1], between 10 to 20 life years are lost [2].”
BackgroundO’Brien, C., Gardner-Sood, P., Corlett, S. K., Ismail, K., Smith, S. M., Atakan, Z., Greenwood, K., Joseph, C., & Gaughran, F. (2013) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12057 · Cited by 20
Tremain, D., Freund, M., Wye, P. M., Wolfenden, L., Bowman, J., Dunlop, A. J., Gillham, K. E., Bartlem, K. M., McElwaine, K., Doherty, E. L., et al. (2016) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2016.05.006 · Cited by 21
Cranwell, K., Polacsek, M., & McCann, T. V. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1567-3 · Cited by 25
Spagnolo, J., Champagne, F., Leduc, N., Melki, W., Piat, M., Laporta, M., Bram, N., Guesmi, I., & Charfi, F. (2018) · BMC Public Health · doi:10.1186/s12889-018-6261-4 · Cited by 19
Moonen, C., Lemiengre, J., & Gastmans, C. (2015) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2015.10.005 · Cited by 20
“These patients are vulnerable, with multiple comorbidities and higher-than-average mortality rates with impact on their life expectancy (Chang et al., 2011; De Hert et al., 2009; Laursen, 2011).”
BackgroundEriksen, C. U., Kamstrup–Larsen, N., Birke, H., Helding, S. A. L., Ghith, N., Andersen, J. S., & Frølich, A. (2022) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565221134017 · Cited by 27
Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders
Omori, N. E., Malys, M. K., Woo, G. H., & Mansor, L. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1142682 · Cited by 21
“Particular research questions warranting targeted investigation include: (1) a direct comparison of the therapeutic effectiveness of KDs versus exogenous ketone supplements; (2) a comparison of KB effectiveness in psychiatric patients with and without known comorbid metabolic disorders (e.”
BackgroundLyngdoh, L. A. M., Antony, S., Basavarajappa, C., Raman, K. J., & Ammapattian, T. (2023) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_797_23 · Cited by 25
“[7,8] SMIs affect a person’s ability to perform roles in society, leading to disability and a burden on caregivers.”
BackgroundFactors associated with changes in hospitalisation in patients prescribed clozapine
Gee, S., Shergill, S. S., & Taylor, D. M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116642745 · Cited by 19
“It is associated with significantly increased morbidity and mortality (Barbato, 1998); life expectancy is reduced by almost 15 years (Chang et al., 2011), not only due to increased risk of suicide or violent death, but also because of the association between serious mental illness and cardiovascular disease, cancer an…”
Backgroundde la Cruz, L. F., Vidal‐Ribas, P., Zahreddine, N., Mathiassen, B., Brøndbo, P. H., Simonoff, E. A., Goodman, R., & Stringaris, A. K. (2017) · Child Psychiatry & Human Development · doi:10.1007/s10578-017-0777-1 · Cited by 22
Das‐Munshi, J., Ashworth, M. J., Gaughran, F., Hull, S., Morgan, C., Nazroo, J. Y., Roberts, A., Rose, D. S., Schofield, P., Stewart, R. J., et al. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1185-8 · Cited by 22
“People living with severe mental illnesses experience a dramatic reduction in life expectancy [1], a large pro-”
BackgroundSelf-citationMouchabac, S., Adrien, V., Falala-Séchet, C., Bonnot, O., Maatoug, R., Millet, B., Peretti, C.-S., Bourla, A., & Ferreri, F. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.622506 · Cited by 21
“The major risk is that the specific care could get to be in function of the societal participation of the patient, marginalizing even more psychiatric patients, already undertreated on the somatic level (57–62).”
BackgroundEdvardsson, K., Hughes, E. A., Copnell, B., Mogren, I., Vicendese, D., & Gray, R. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264512 · Cited by 21
Smith, J. M., Knaak, S. J., Szeto, A. C. H., Chan, E. C., & Smith, J. D. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-022-00801-5 · Cited by 25
“…life expectancy for those diagnosed with schizophrenia, bipolar disorder, schizoaffective disorder, depressive disorder, and substance use disorder (Chang et al., 2011; * Jacqueline M. Smith jacqueline.smith1@ucalgary.ca 1 Faculty of Nursing, University of Calgary, Calgary, AB, Canada 2…”
BackgroundCoyne, E., Briggs, J., Loud, F. C., Bristow, P., Young, H. M. L., Castle, E. M., Lightfoot, C. J., Graham-Brown, M. P. M., Eyre, M., Ormandy, P., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad116 · Cited by 20
“People living with severe mental illness make up 7% of the UK kidney population [6–8], receive suboptimal kidney care and can die up to 15 years younger than their peers.”
BackgroundSeya, M. K. S., Matthews, S., Zhu, L., Brown, C., Lefevre, A., Agathis, N. T., Chiang, L. F., Annor, F., McOwen, J., Augusto, Â. D. R., et al. (2023) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2023.106493 · Cited by 23
Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness
Wu, S., Kao, K., Chen, S., Juang, J. J., Lin, C., Fang, C., Wu, C., Dewey, M. E., Prince, M. J., & Stewart, R. J. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12345 · Cited by 22
“With cardiovascular diseases being the leading cause of death, research has found an 11– 20 years reduction in life expectancy among people with bipolar disorder or schizophrenia (3, 4).”
BackgroundSelf-citationGossage-Worrall, R., Holt, R. I. G., Barnard-Kelly, K. D., Carey, M., Davies, M. J., Dickens, C. M., Doherty, Y., Edwardson, C. L., French, P., Gaughran, F., et al. (2016) · Trials · doi:10.1186/s13063-016-1572-1 · Cited by 20
Gossage-Worrall, R., Hind, D., Barnard-Kelly, K. D., Shiers, D., Etherington, A., Swaby, L., & Holt, R. I. G. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2282-5 · Cited by 20
Reckziegel, R. D. F. X., Czepielewski, L. S., Hasse-Sousa, M., Martins, D. S., de Britto, M. J. S., Lapa, C. D. O., Schwartzhaupt, A. W., & Gama, C. S. (2022) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1670 · Cited by 25
Adjunctive Behavioral Activation for the Treatment of Bipolar Depression: A Proof of Concept Trial
Weinstock, L. M., Melvin, C., MUNROE, M. K., & Miller, I. W. (2016) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000142 · Cited by 18
Physical Activity Mode and Mental Distress in Adulthood
Sciamanna, C., Smyth, J. M., Doerksen, S. E., Richard, B. R., Kraschnewski, J. L., Mowen, A. J., Hickerson, B. D., Rovniak, L. S., Lehman, E. B., & Yang, C. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.09.014 · Cited by 29
Alegria, M. M., Drake, R. E., Kang, H., Metcalfe, J. D., Liu, J., DiMarzio, K., & Ali, N. (2017) · Health Affairs · doi:10.1377/hlthaff.2017.0044 · Cited by 19
The emergence of antidepressant drugs targeting GABAA receptors: A concise review
Gonda, X., Tarazi, F. I., & Döme, P. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116481 · Cited by 19
The ENBREC study group, Henry, C., Andreassen, O. A., Barbato, A., Demotes‐Mainard, J., Goodwin, G. M., Leboyer, M., Vieta, E., Nolen, W. A., Kessing, L. V., et al. (2013) · International Journal of Bipolar Disorders · doi:10.1186/2194-7511-1-2 · Cited by 19
When psychiatric symptoms reflect medical conditions
Welch, K. A., & Carson, A. J. (2018) · Clinical Medicine · doi:10.7861/clinmedicine.18-1-80 · Cited by 17
Acute hospital service utilization by inpatients in psychiatric hospitals
Lally, J., Wong, Y. L., Shetty, H., Patel, A. K., Srivastava, V., Broadbent, M. T. M., & Gaughran, F. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.07.006 · Cited by 18
Self-citationPalliative care for people with serious mental illnesses
Sheridan, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30205-1 · Cited by 21
Cranwell, K., Polacsek, M., & McCann, T. V. (2016) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12322 · Cited by 21
Korhonen, K., Moustgaard, H., Tarkiainen, L., Östergren, O., Costa, G., Urhøj, S. K., & Martikainen, P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.076 · Cited by 20
Viron, M., Zioto, K., Schweitzer, J., & Levine, G. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.03.009 · Cited by 21
Williamson, K., Kilner, K., & Clibbens, N. (2015) · Journal of Nutritional Science · doi:10.1017/jns.2015.18 · Cited by 18
Mathur, R., Hull, S., Boomla, K., & Robson, J. P. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x653642 · Cited by 18
Brown, T., McKenna, B., & Furness, T. (2017) · International Journal of Mental Health Nursing · doi:10.1111/inm.12327 · Cited by 17
Lally, J., Loughlin, A. O., Stubbs, B., Guérandel, A., O'Shea, D. B., & Gaughran, F. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1445968 · Cited by 19
Das‐Munshi, J., Semrau, M., Barbui, C., Chowdhary, N., Gronholm, P. C., Kolappa, K., Krupchanka, D., Dua, T., & Thornicroft, G. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02623-y · Cited by 19
Werneck, A. O., Schuch, F. B., Stubbs, B., Oyeyemi, A. L., Szwarcwald, C. L., Vancampfort, D., & da Silva, D. R. P. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-1073 · Cited by 16
Newbronner, E., Spanakis, P., Wadman, R., Crosland, S., Heron, P., Johnston, G., Walker, L. E., Gilbody, S. M., & Peckham, E. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.799885 · Cited by 20
Intervention précoce pour la psychose : concepts, connaissances actuelles et orientations futures
Iyer, S. N., & MALLA, A. K. (2014) · Santé mentale au Québec · doi:10.7202/1027840ar · Cited by 23
Chue, P. S., & Chue, J. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s81581 · Cited by 16
“There is a high rate of comorbidity, particularly with substance use and anxiety disorders and, similar to schizophrenia and bipolar disorder, life expectancy in patients with SCA is decreased compared with the general population.(11) While, approximately one-third of patients presenting in outpatient settings have a…”
BackgroundBlane, D., Mackay, D., Guthrie, B., & Mercer, S. W. (2016) · British Journal of General Practice · doi:10.3399/bjgp16x688405 · Cited by 17
“The study also adds to the large body of evidence on disparities between those with physical and mental health problems.(5, 45, 46) Improving integration and co-ordination of care for people with multimorbidity is one of the key healthcare challenges of the 21 century.”
BackgroundVancampfort, D., Wyckaert, S., Sienaert, P., Hert, M. D., Soundy, A., Rosenbaum, S., Richards, J. A., & Probst, M. (2016) · PubMed · Cited by 18
Chang, E., Chen, S., Chiang, J., Wang, L., Hsu, C. Y., & Shen, Y. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12802 · Cited by 15
Metadata
- Authors
- Chang, C.-K., Hayes, R. D., Perera, G., Broadbent, M. T. M., Fernandes, A. C., Lee, W. E., Hotopf, M., & Stewart, R.
- Affiliations
- King's College London (GB)
- South London and Maudsley NHS Foundation Trust (GB)
- Corresponding author
- Chang, Chin-Kuo
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-05-18
- Volume
- 6
- Issue
- 5
- Pages
- e19590
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3097201
- OpenAlex
- W2010135111
- Cited by
- 714
- References
- 44
- Citations by year
- 2026: 17 · 2025: 38 · 2024: 42 · 2023: 45 · 2022: 68 · 2021: 54 · 2020: 62 · 2019: 53 · 2018: 54 · 2017: 46 · 2016: 65 · 2015: 50 · 2014: 52 · 2013: 38 · 2012: 24
- FWCI
- 51.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- life expectancy at birth, severe mental illness, mortality gap, premature mortality, schizophrenia, schizoaffective disorder, bipolar disorder, substance use disorders, depressive disorders, years of life lost, sex differences, secondary mental health care, South London and Maudsley NHS Foundation Trust
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Demography, Female, Humans, Life Expectancy, London, Male, Mental Health, Middle Aged, Registries, Wales, Age Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
